Back to Search

TRAVIS HUGHES, MD

MD

Vascular Surgery Physician

NPI: 1801327184IndividualAccepts Medicare

Specialties, Licenses & Credentials

Surgery Physician

Surgery

Code: 208600000X

R4443(KY)
Student in an Organized Health Care Education/Training Program

Student in an Organized Health Care Education/Training Program

Code: 390200000X

Vascular Surgery PhysicianPrimary

Surgery — Vascular Surgery

Code: 2086S0129X

ME179908(FL)56726(KY)

CMS Specialties

PrimaryVASCULAR SURGERY

Education

OTHER

Class of 2017

Research & Publications (20)

Underestimation of mortality due to chronic obstructive pulmonary disease (COPD) in Kentucky.
PMID 16939035·J Ky Med Assoc·2006
4-observational
Evidence that opioids may have toll-like receptor 4 and MD-2 effects.
PMID 19679181·Brain Behav Immun·2010
7-preclinical
Fractionated subcutaneous rituximab is well-tolerated and preserves CD20 expression on tumor cells in patients with chronic lymphocytic leukemia.
PMID 19679883·Haematologica·2010
3-trial
Imatinib mesylate causes growth plate closure in vivo.
PMID 19626049·Leukemia·2009
7-preclinical
Feasibility of T2* mapping for the evaluation of hip joint cartilage at 1.5T using a three-dimensional (3D), gradient-echo (GRE) sequence: a prospective study.
PMID 19645008·Magn Reson Med·2009
8-other
Immunological priming potentiates non-viral anti-inflammatory gene therapy treatment of neuropathic pain.
PMID 19571887·Gene Ther·2009
7-preclinical
An evaluation of maxillary and mandibular rotational responses with the Clark twin block appliance.
PMID 19634464·Aust Orthod J·2009
8-other
Clinical strategies to achieve an early and successful response to tyrosine kinase inhibitor therapy.
PMID 19621544·Semin Hematol·2009
8-other
Immunogenicity of intrathecal plasmid gene delivery: cytokine release and effects on transgene expression.
PMID 19533588·J Gene Med·2009
7-preclinical
Dasatinib or high-dose imatinib for chronic-phase chronic myeloid leukemia resistant to imatinib at a dose of 400 to 600 milligrams daily: two-year follow-up of a randomized phase 2 study (START-R).
PMID 19536906·Cancer·2009
3-trial

Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.

Request Appointment

This provider isn't set up for online booking yet. Once you submit, we'll reach out to their office to arrange secure delivery of your request.

Contact & Hours

Via practice · 2 locations total

Address
740 S LIMESTONE STE L119
LEXINGTON, KY 40536

Locations (2)

Practice Location

740 S LIMESTONE STE L119, LEXINGTON, KY
(859) 323-3253

Practice Location

2 TAMPA GENERAL CIR, TAMPA, FL
(813) 974-8317

Quick Facts

NPI
1801327184
Entity Type
Individual
Gender
Male
Medicare
Accepted
Specialties
4
Locations
2
Years in Practice
9
Publications
20

Are you this provider?

Claim Your Profile